Ingevity Corp NGVT.N, NGVT.K is expected to show a fall in quarterly revenue when it reports results on November 5 for the period ending September 30 2025
The North Charleston South Carolina-based company is expected to report a 4.4% decrease in revenue to $360.433 million from $376.9 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for Ingevity Corp is for earnings of $1.39 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Ingevity Corp is $69.50, about 22.7% above its last closing price of $53.72
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2025 | 1.18 | 1.16 | 1.39 | Beat | 19.6 |
Mar. 31 2025 | 0.69 | 0.74 | 0.99 | Beat | 34.2 |
Dec. 31 2024 | 0.27 | 0.31 | 0.95 | Beat | 208.9 |
Sep. 30 2024 | 0.90 | 0.90 | 1.10 | Beat | 22.2 |
Jun. 30 2024 | 1.07 | 1.05 | 1.01 | Missed | -4.2 |
Mar. 31 2024 | 0.33 | 0.32 | 0.52 | Beat | 62.5 |
Dec. 31 2023 | -0.18 | -0.19 | 0.21 | Beat | 210.5 |
Sep. 30 2023 | 1.22 | 1.22 | 1.21 | Missed | -0.4 |
This summary was machine generated November 3 at 21:01 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)